A$73M for Rx drug packaging in Australia
The Australian government has announced a package worth A$72.9 million ($59.7 million) for packaging improvements by pharmacies to help patients manage their drugs better. The program provides support to community pharmacists to help patient compliance by packaging the drugs according to the daily dose schedule.
The funds have been provided by the Commonwealth Government to the Pharmacy Guild of Australia under the Fourth Pharmacy Agreement for the Dose Administration Aids program, which expires in June 2010. Pharmacies will be provided with details of the scheme during September and October.
The repackaged drugs would be either in unit-dose (one drug per compartment) or multi-dose (different drugs in a compartment) packs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze